• AHA: Physical Activity Best First-line for High BP, Cholesterol

  The optimal first step to address mild to moderately elevated blood pressure and cholesterol in otherwise healthy adults is a "prescription" to sit less and move more, the American Heart Ass

  2021-05-02

• Once-Nightly Sodium Oxybate Agent Effective in Narcolepsy

  A novel, once-nightly formulation of sodium oxybate is safe and effective for treating both subjective and objective symptoms of narcolepsy, new research suggests.Top-line results from the phase 3 RES

  2021-04-21

• Anal Cancer: Risk Factors, Diagnosis, and Management

  Image courtesy of David E. Stein, MD, MHCM.Anyelin Almanzar, MD; Edward A. Fazendin, MD; Alexander J. Crean, MD; David E. Stein, MD, MHCM | April 15, 2020 | Contributor InformationAnal cancer is

  2021-04-21

• Discrimination of single-point mutations in unamplified genomic DNA via Cas9 immobilized on a graphene field-effect transistor

  Simple and fast methods for the detection of target genes with single-nucleotide specificity could open up genetic research and diagnostics beyond laboratory settings. We recently reported a biosensor

  2021-04-20

• Six Pregnancy Complications Flag Later Heart Disease Risk

  Six pregnancy-related complications increase a woman's risk of developing risk factors for cardiovascular disease (CVD) and subsequently developing CVD, the American Heart Association (AHA) says i

  2021-04-09

• BP Lowering Useful in CV Risk Management Even at Normal Levels

  Lowering blood pressure with antihypertensive medication protects against future cardiovascular (CV) events even in people with normal or only mildly elevated blood pressure, a large meta-analysis con

  2021-04-05

• AHA Issues New Advice on Managing Stage 1 Hypertension

  Clinicians should consider the use of medication for adults with untreated stage 1 hypertension (130–139/80–89 mm Hg) whose 10-year risk for atherosclerotic cardiovascular disease 

  2021-04-04

• Percutaneous radiofrequency ablation for atrial fibrillation

  The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on percutaneous radiofrequency catheter ablation f

  2021-04-02